483 Roundup: FDA Cites Four Drugmakers for Serious Violations

Drug GMP Report
A A
The FDA hit four drugmakers for a variety of issues, including bug infestations, environmental monitoring and poor record keeping.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $200.00